BRAINSTORM CELL THERAPEUTICS INC. Common Stock Shares Outstanding

Quick Answer

BRAINSTORM CELL THERAPEUTICS INC. reported Common Stock Shares Outstanding of 11.03 million shares for the year ending 2025.

  • BRAINSTORM CELL THERAPEUTICS INC. showed an increase of +79.7% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from BRAINSTORM CELL THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), BRAINSTORM CELL THERAPEUTICS INC.'s Common Stock Shares Outstanding has declined by 88.5%.
  • Historical annual values: Fiscal year 2025: 11.03 million shares | Fiscal year 2024: 6.14 million shares | Fiscal year 2023: 4.03 million shares | Fiscal year 2022: 36.69 million shares | Fiscal year 2021: 36.40 million shares | Fiscal year 2020: 35.16 million shares | Fiscal year 2019: 23.17 million shares | Fiscal year 2018: 20.76 million shares | Fiscal year 2017: 18.98 million shares | Fiscal year 2016: 18.69 million shares | Fiscal year 2015: 18.64 million shares | Fiscal year 2014: 15.28 million shares | Fiscal year 2013: 11.75 million shares | Fiscal year 2012: 150.09 million shares | Fiscal year 2011: 126.44 million shares | Fiscal year 2010: 95.83 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: